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Introduction: As one of the most common and invasive brain tumors, 
glioblastoma which originates in the nervous tissue of the brain has remained 
a therapeutic challenge given low success of conventional therapies. Small 
molecules including GW9508, due to their different roles in signaling and 
intracellular pathways and the production and increase of oxidative stress of 
mitochondrial origin, can cause cells to progress to apoptosis, also known as 
a cost-effective pharmacological factor. Therefore, in the present study, the 
anticancer and cytotoxic effects of GW9508 on A549 class lung cancer cells 
were investigated. 
Materials and Methods:  In this experiment, the cell line (C118) was firstly 
cultured in DMEM culture medium containing 10% FBS and then treated with 
different concentrations of GW9508. MTT assay was used to determine IC50 
and compare the viability of treated cells with different concentrations of 
GW9508 on days 1, 3, and 5 in the control group. To evaluate the effect, the 
qRT-PCR test was used with the IC50 concentration on the induction of 
apoptosis and expression of the P53 gene. 
Results: The results showed that GW9508 significantly reduced the viability 
and proliferation of C118 cells in a dose- and time-dependent manner (P 
<.05). Morphological changes such as reduction of chromatin density and cell 
rotation were also observed in the cells. Also, molecular results showed that 
GW9508 was able to increase the expression of the P53 gene. 
Conclusions: The GW9508 small molecule induces cell death in glioblastoma 
cancer cells by reducing cell viability and increasing P53 gene expression. As 
a result, it has therapeutic potential to induce cell death in cancer cells and to 
treat cancer. 
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1. Introduction 
   Brain tumors are one of the major diseases 
that have caused many deaths. Eighty 
percent of primary brain tumors are 
malignant and thirty percent of all central 
nervous system tumors are caused by 
gliomas [1]. Glioblastoma tumors are 
multiform and one of the most aggressive 
and most common brain tumors with brain 
nervous tissue origin. They are in fact 
produced in the star-shaped cells in brain 
called astrocytes. These types of tumors are 
attached to the bloodstream through 
angiogenesis and therefore grow rapidly. 
Despite all the advances made in the 
treatment of this type of tumor, the survival 
rate with this tumor is so low (about 13-14 
months) that only about three percent of 
patients have a survival rate of more than 4 
years [3]. Of the main factors causing cancer 
are environmental factors such as 
mechanical damage and electromagnetic 
radiation. Yet, in addition to the role of 
environmental factors, disruption of many 
subcellular pathways such as RAS/PI3K and 
PI3K/PTYEN/AKT/mTOR can contribute to 
the development of this cancer [4]. 
Moreover, due to vascular proliferation of 
glioblastoma tumors, three pathways 
including p53 pathway, tyrosine receptor 
kinase signaling pathway, RAS, 
phosphoinositide-3 kinase (PiK3), and 
retinoblastoma pathway are associated with 
this cancer. Also, different types of primary 
and secondary glioblastoma are caused by 
different changes in these pathways [5]. The 
P53 gene is one of the most important tumor-
inhibiting genes mutating in half of all 
cancers. In fact, when DNA is damaged, the 
cell enters the S or M stage. In this case, the 
concentration and activity of P53 protein 
increases and changes from inactive to active 
form. P53 encodes a 53 kDa nuclear 
phosphoprotein whose natural function is to 
protect the genome from damage. This 
process leads to genome repair and if not 
repaired, P53 induces cell death by inducing 
cell apoptosis, thus eliminating carcinogenic 
cells [6]. 
The standard treatment for glioblastoma 
multiform involves maximal surgical 
resection of the tumor followed by 
radiotherapy between 1 and 2 weeks after 
surgery [7]. Despite extensive clinical and 
paraclinical research to increase the lifespan 
of patients with glioblastoma tumor, the 
disease does not have a good prognosis for 
patients, remaining a therapeutic challenge 
for neuro-oncologists and neurosurgeons. 
Resistance of innate glioblastoma tumor to 
chemotherapy and radiotherapy, inability to 
surgically remove the tumor due to the 
aggressive nature of the tumor, presence of a 
blood-brain barrier that restricts drug access 
to the tumor site, and neurotoxicity of 
therapeutic agents that limit the dosage of 
drugs are the reasons behind the low success 
rate of common therapeutic measures [8]. 
Because of this, nowadays, some effective 
small molecules in inducing apoptosis 
(programmed cell death) with few side 
effects have been identified [9]. In fact, 
apoptosis is the basis for new therapeutic 
targets that induce cancer cell death or 
sensitivity to cytotoxic agents and the effect 
of radiation therapy. Therefore, this process 
along with substances that can induce cell 
death and expression of proapoptic genes has 
been extensively studied by cancer 
researchers [10]. GW9508 is one of these 
small molecules which play different roles in 
signaling and intracellular pathways, being 
able to cause cell progression to apoptosis 
and autophagy by causing and increasing 
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oxidative stress of mitochondrial origin. 
Studies show that GW9508 is an agonist for 
the G protein-coupled receptor 40 (GPR40). 
GPR40 is a receptor for long-chain 
unsaturated fatty acids (FFAR1), which is a 
type of G protein-coupled receptor, and 
through this receptor, it induces biological 
functions such as inducing osteogenic 
differentiation in osteocyte precursor cells 
[12, 13]. 
Taking such findings into account, this study 
aimed to evaluate the effect of GW9508 
small molecule on cytotoxicity and 
expression of P53 gene in glioblastoma or 
C118 cancer cell line.  
2. Materials and Methods 
Preparing the GW9508 solution 
  GW9508 was purchased as a powder from 
Sigma Company and in order to prepare the 
main stock solution, it was dissolved in 
sterile conditions with DMSO (10ml) and 1, 
10, 25, 50, and 100 μM of GW9508 solution 
was prepared as doses used in cell culture 
and after the filtration using .22 μm syringe 
filter (Bio Fact BSS20-PE2, Korea) it was 
kept at 4°C until use. 
Cell culture and passage: 
In this study, astrocytoma cell line (C118) 
was provided from Pasteur Institute of 
Tehran and then cultured in DMEM culture 
medium (Gibco, USA) containing 10% fetal 
bovine serum (Gibco, USA), stored in the 
incubator (Ependorf, Germany) with 5% 
CO2, 95% humidity and 37 °C temperature. 
After cell passage, cells were cultured with 
approximately 7× 103 cells/cm2 in 96-well 
plate containing complete culture medium. 
Twenty-four hours later, cells with different 
concentrations of small molecules were 
cultured and cell viability was evaluated at 
days 1, 3, and 5. 
Cell viability assay by MTT colorimetric 
assay 
The viability of cancer cells treated with 
different concentrations of GW9508 small 
molecules was measured by MTT method 
(4,5 3-(Dimethylthiazol-2-yl) -2,5-
Diphenyltertrazolium Bromide). Also, using 
MTT test inhibition concentration of 50% or 
IC50 of GW9508 small molecule was also 
determined. The basis of this test is the 
reduction of tetrazolium salt by the 
mitochondrial enzyme of succinate 
dehydrogenase of living cells and becoming 
insoluble formazan (purple). The absorption 
of purple dye at a wavelength of 570 nm was 
measured using ELISA reader (Fax 2100, 
USA). For this purpose, 1× 104 cells/cm2 
were cultured in 96-well plates and 
incubated for 24 hours. Then, the cells were 
treated with concentrations of 1, 10, 25, 50, 
and 100 μM of GW9508 and cell viability 
was assessed at days 1, 3, and 5. A control 
group was considered for each cell that 
remained untreated. Then, MTT test was 
done, so that at the desired times, the 
environment was taken out of the wells and 
to each well about 100 μl of fresh medium 
containing 10 μM of MTT solution (with a 
concentration of 5 mg/ml) was added. Cells 
were kept for 3 hours in the incubator and 
were incubated at 37°C and then the MTT 
solution was removed and 100 μl of DMSO 
(Bioidea, Iran) was added to each well. The 
optical absorption of samples was measured 
at 570 nm using a microplate reader (Stat fax 
2100, Florida, USA). The following formula 
was used to calculate the percentage of cell 
viability: 
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Cell viability (%) = OD treatment group / 
OD control group × 100 
Morphologic evaluation using imaging 
For morphological examination of C118 
cells from control and treated groups, with 
IC50 concentrations of GW9508 small 
molecule on days 1, 3, and 5 in 96-well plates 
were taken by a digital camera connected to 
a reverse microscope with 20 and 40 object 
lenses, and microscopic images were 
evaluated and compared for each cell in the 
control and treated groups. 
Morphological study with acridine 
orange/ethidium bromide staining 
This cell staining is a fluorescence technique 
that uses two fluorescent dyes, namely 
acridine orange and ethidium bromide 
(Sigma, USA). For fluorescence microscopy 
to study cell apoptosis, the cells were first 
prepared with stock 1 mg/ml acridine orange 
dye and stock 1 mg/ml ethidium bromide dye 
and mixed in equal proportions. Then cells 
were treated with IC50 concentrations of 
GW9508 small molecule on days 1, 3, and 5 
in 96-well plates of cell treatment acridine 
orange/ethidium bromide dye was added to 
the cells at a concentration of 100 μg/ml and 
after 5 minutes they were examined and 
imaged by a microscope. 
RNA extraction and fabrication of cDNA: 
RNA extraction was performed according to 
the kit protocol of extraction of the Cinnagen 
(an Iranian company). All steps were taken 
accordingly, using the kit solutions. The 
nanodrop device was used to measure RNA 
and the character and size of RNAs at 
280/260 nm. By cDNA synthesis Kit (Taq 
Man Reverse Transcription Kit, GeneAll, 
Portugal) and according to the kit protocol, 
for each sample, 2 μl of synthesized cDNA, 
0.5 μl of Forward Primer, 0.5 μl of Reverse 
Primer, 2μl of SYBR Green and 5 μl of 
distilled water using Power SYBER Green 
master mix (Qiagen, Japan) in the final 
volume of 10 μl was performed by Real-
Time PCR. Data analysis (CT) of each 
sample were done using StepOne software 
and normalization using GAPDH gene 
(housekeeping control gene) to estimate the 
percentage of changes (Fold Change) of the 
expression of P53 gene compared to the 
difference of GAPDH gene threshold cycle 
between control samples (without treatment 
with the drug) relative to the sample treated 
with small molecules. Each experiment was 
repeated three times. 
Design and synthesis of primers 
The primers used in this study are based on 
the relevant gene sequences obtained from 
the NCBI site and the direct and inverse 
primers are designed using Gen runner and 
primer express software. The relevant 
sequences are shown in the table below. 
Real Time PCR 
In order to amplify the desired fragment and 
synthesize the cDNA of the RT-PCR 
reaction after reverse transcription reaction, 
the SYBR Green kit was used. We then ran 
the thermal cycler program to measure gene 
expression. Finally, the required temperature 
and time using the SYBR Green Kit protocol 
were designed and determined. According to 
the schedule, in stage one, denaturation 
reaction was performed at 95 °C for 30 
seconds, then melting was performed at 95 
°C for 1 second, and finally the third stage, 
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Statistical analysis 
The Livak method was used to analyze the 
data obtained from this reaction. GraphPad 
Prism, one-way ANNOVA, and t test were 
also used for statistical analysis. P <.05 is 




  Evaluation of morphology of C118 cells 
treated with GW9508 small molecule by 
inverted microscope  
Observation of cell morphology under 
inverted microscope showed that IC50 
concentration of GW9508 small molecule 
caused the cell rounding and shrinkage of 
C118 cells treated compared to control group 
cells. In fact, the treated cells were 
significantly different from the control group 
cells. Thus, shrinkage and reduction of the 
cell volume, condensation of nucleus, 
reduction of cytoplasm volume, loss of 
morphology of cell colony as well as cell 
communication and interaction, and 
appearance of single cells were seen in the 
image examinations. This indicates that this 
concentration has a toxic effect, causing 





Figure 1. Morphology of class C 118 cells with conventional inverted microscope: A - control group cells (20X 
magnification) B - cells treated with IC50 concentration of GW9508 small molecule for 24 hours - shrinkage and 
reduction of cell volume, densification of the nucleus, reduction of cytoplasm volume, and loss of cell colony 
morphology indicate the toxicity of these concentrations and the progression of cells to apoptosis. 
  Effect  
 
 





GW9508 and P53 in C118 Cell Line, Entezari  M et al.      
 
Evaluation of morphology of C118 cells 
treated with GW9508 small molecule in 
acridine orange / ethidium bromide 
staining 
Two fluorescent dyes (i.e., acridine orange 
and ethidium bromide) and a fluorescent 
microscope were used to evaluate cell 
apoptosis. Acridine is a cellular dye that 
naturally crosses cell membranes and turns 
the nucleus of living cells green. Ethidium 
bromide passes only through injured 
membranes and turns the nucleus of 
apoptotic cells orange, and if the cell is in the 
late stages of apoptosis, the nucleus becomes 
compressed, fragmented, and red. C118 cells 
were treated with IC50 concentration of 
GW9508 small molecule stained with 
acridine orange/ethidium bromide dyes and 
examined by fluorescent microscope. In 
C118 cells treated with IC50 concentrations 
of small molecules, the nuclei of the cells 
were isolated individually compared to the 
control group where the nuclei of the cells 
were grouped together. Also, the nuclei of the 
control group cells are round, large, clear, and 
green, indicating that they are alive, and the 
cells of the group treated with this compound, 
with a single, dense orange nucleus, confirm 
apoptosis (Fig. 2). 
 
Figure 2 - Evaluation of apoptosis using acridine orange/ethidium bromide staining of C118 cells: A- control group cells 
(40X magnification) B- cells treated with IC50 concentration of GW9508 small molecule for 24 hours - in orange 
treatment groups of cells confirms cell apoptosis and green indicates live cells in the control group. 
 
The effect of GW9508 small molecule on 
C118 cell viability: 
Intensity of light absorption obtained from 
C118 cancer cells which were treated for 21 
hours with different concentrations (1, 10, 25, 
50, and 100 μM) of GW9508 small molecule 
was compared to the average light absorption 
of control cells that were not treated with the 
drug. The results of evaluating cell viability 
based on MTT test and growth inhibition 
percentage in cells treated with different 
concentrations of GW9508 small molecule 
are shown in graph 1. Based on MTT test 
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results, IC50 concentration of GW9508 small 
molecule in 24 hours for C118 cells is 25 μM. 
The results confirm that the toxicity of this 
compound is dose-dependent on the viability 
rate of C118 cells and significantly reduces 
cell viability by increasing the concentration. 
 
Graph 1- Effects of different concentrations of GW9508 small molecule on the viability of C118 cells using MTT test and 
determination of 25 μM concentration as the IC50 of C118 cells (Different letters shows significant difference between 
groups (P <.05). Arrow indicates the IC50 concentration. 
 
 
Evaluation of C118 treated cell viability 
with IC50 concentration of GW9508 on 
days 1, 3, and 5 
The viability rate of C118 cells on days 1, 3, 
and 5 in the treated group with IC50 
concentration in 25 micromolar of GW9508 
small molecule was compared with the 
control group. The viability percentages of 
treated cells on days 1, 3, and 5 were 42%, 
35% and 29%, respectively. Viability of 
treated cells in day 5 was significantly 
reduced compared to treated cells in day 3 
and day1. In addition, on the third day, the 
viability rate of treated cells was lower than 
the first day, which indicates time and dose 
dependence of the effect of GW9508 small 
molecule on C118 cells (P <.05).
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Graph 2. The effect of GW9508 small molecule on viability rate of C118 cells on days 1, 3, and 5 after the treatment (P 
<.05). 
 
The evaluation of P53 expression change 
in C118 cells treated with the IC50 
concentration of GW9508 small molecule 
As you can see in the graph 3, the results of 
gene analysis in the group treated with 
GW9508 small molecule show that the 
expression of P53 gene repressor in 24-hour 
treated cells with IC50 concentration of the 
small molecule significantly increased 
compared to the control group (P <.05), 
indicating apoptotic cell death in C118 
cancer cells. 
 
Graph 3- Changes in P53 gene expression in C118 cells under 24-hour treatment with IC50 concentration of GW9508 
small molecule (G1): Increased expression of P53 gene in C118 cells treated with IC50 concentration of the small 
molecule in C118 cell line compared to GAPDH gene indicates induction of apoptotic death in cancer cells by this 
substance (P<.05, IC50 GW9508= 25mM). 
 
  Effect  
 
 





















Graph 5 - Melting curve of P53 Gen 
  Effect  
 
 





GW9508 and P53 in C118 Cell Line, Entezari  M et al.      
 
 4. Discussion 
   Glioma is a type of tumor engaging the 
central nervous system (CNS) and one of the 
most acute malignant tumors in adults 
caused by the abnormal division of neuroglia 
cells [14]. Methods for treating the acute 
glioma based on its type, the incidence place, 
extent of the tumor, and the patient's general 
health are determined by surgery and 
removal of the tumor, radiation therapy, the 
use of anticonvulsants and corticosteroids, 
and chemotherapy with DNA alkylation 
agents such as temozolomide. Due to the side 
effects, costs, and ineffectiveness of 
therapies, there is a need to look for new 
methods and strategies to prevent the disease 
[15]. Years ago, small molecules in the 
pharmacology were known as a chemical 
probe and/or as a mutation factor. Since 
these molecules weigh less than 900 Daltons, 
they have a permissible range of molecules 
through the cell membrane to reach 
intracellular target positions. These 
compounds play a regulatory role in the 
physiological processes of different 
functions [16]. GW9508 is one of these small 
molecules that is the GPR40 receptor agonist 
and plays different roles in messenger 
pathways and intracellular pathways. This 
small molecule through generating and 
increasing oxidative stress of mitochondrial 
origin can cause the cell to progress to 
apoptosis and autophagy [15]. Recent studies 
have shown that unsaturated fatty acids, 
including linoleic acid, play an important 
role in the treatment of cancer and act as 
extracellular signaling molecules by binding 
to G protein-coupled fatty acid receptors. 
GPR40 can also induce oxidative stress and 
apoptosis in pancreatic beta cancer cells [17]. 
In this study, C118 glioblastoma cancer cells 
were treated with different concentrations of 
GW9508 small molecule, then cell viability, 
cell growth, and proliferation were evaluated 
on days 1, 3, and 5 after. According to MTT 
analysis, the concentration of 25 μM was 
determined as the IC50 concentration for the 
GW9508 small molecule. The imaging 
results of this study showed that GW9508 
could cause significant changes in the 
morphology of C118 cells, including 
lowering the cytoplasm of cells and their 
shrinkage. These changes were evident in 
both conventional and acridine orange 
staining. The mentioned substance 
significantly reduced the growth and 
proliferation of C118 cells compared to 
control cells. The rate of induction of cell 
death by GW9508 was directly related to the 
increase in its concentration and duration of 
treatment. Also, the study of apoptosis and 
P53 gene analysis using the PCR method 
showed that the test compound stimulates 
and increases the expression of P53 gene in 
C118 cells. Therefore, according to the 
results, it can be said that GW9508 increases 
the cytotoxicity and induces apoptosis in 
cancer cells. So far, many in vitro studies 
have been conducted, to a lesser extent in 
animal models, to evaluate the anti-cancer 
effect of fatty acids as well as agonists of 
fatty acid receptors on different cell lines. 
For example, recent clinical studies have 
shown a potential link between long-chain 
unsaturated fatty acids and some cancers. 
Unsaturated free fatty acids exert anticancer 
and cytotoxic properties through different 
metabolic pathways (18). Pierre et al. (2013) 
studied the effects of Trance-10, cis-12 CLA 
on the induction of cell death in human 
colorectal cancer, arguing that this substance 
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causes apoptosis in colon cancer cells by 
increasing the production of ROS originating 
in the endoplasmic reticulum. Their studies 
indicated that CLA-treated tumor cell 
growth was suppressed by inducing 
apoptosis and inhibiting cell cycle along with 
angiogenesis. 
Their studies also showed that apoptosis 
occurs in the mitochondrial membrane [19]. 
There's strong evidence of the relative 
inhibitory effect of omega-3 fatty acids on 
many human cancers [20] including breast 
cancer [21]. In breast cancer, inhibitory and 
stimulatory effects of tumors with various 
GPR40 receptor agonists demonstrate that 
the use of omega-3 fatty acids or synthetic 
GPR40 agonists such as GW9508 and TUG-
891 also inhibit tumor growth [22]. In 
another study, the agonistic effect of free 
fatty acid receptors (FFAR), including the 
GW9508 small molecule, on the 
proliferation of MDA-MB-231 breast cancer 
cells and MCF-7 cell line has been 
investigated. The results of this study 
indicate that this compound inhibits the 
proliferation of cancer cells. GW9508 is a 
specific agonist of FFA1, has very high 
cytotoxicity, and prevents the migration and 
metastasis of MCF-7 breast cancer cells. The 
PCR results of this study indicate that the 
gene and protein of FFAR, including 
GPR40, are expressed in breast cancer. 
Additionally, activation of FFAR receptors 
by GW9508 agonist proliferation and cell 
migration inhibits MDA-MB-231 and MC7-
7 cancer [23]. The results of the present study 
are in line with those of recent studies, as it 
was observed in this study that GW9508 
small molecule increases the cytotoxicity 
and induces apoptosis in glioblastoma cancer 
cells. This might be because GW9508 is an 
agonist with GPR40, which leads to the 
induction of oxidative stress of 
mitochondrial origin and cell death in cells 
[24]. Since the apoptotic process has two 
intrinsic pathways with the mitochondrial 
origin and an extrinsic pathway induced by 
death receptors, the rate of death induced by 
superficial death receptors is higher than that 
of mitochondrial pathway [25]. Thus, 
GW9508 with triggering this pathway causes 
cell death, DNA fragmentation, chromatin 
condensation, and cell shrinkage, all of 
which were found in this study. Another 
study conducted in 2018 by Behnoosh 
Rafieinia et al. on the HT29 cell line showed 
that the viability of cells treated with specific 
doses of GW9508 was reduced. Bcl-2 
expression levels decreased while Bax and 
Bad expression decreased compared to the 
control group; as a result, GW9508 could 
have anticancer and cytotoxic effects in 
which case it could be used for the treatment 
of cancers [26]. In this study, it was found 
that the GW9508 small molecule has the 
power to significantly increase the 
expression of the tumor suppressor gene or 
P53. Because the P53 molecule is one of the 
most important inhibitors of the cell cycle, 
this molecule inhibits the cell cycle by 
interrupting the G1/S phase and prevents 
tumor formation by inducing apoptosis [27].  
Given that, GW9508 inhibited cell cycle in 
C118 cells by inducing P53 gene expression, 
and induced cell death. Also, due to vascular 
proliferation of glioblastoma tumors, three 
pathways related to this cancer have been 
identified, one of which is the p53 pathway. 
Different types of primary and secondary 
glioblastoma are caused by various changes 
in these pathways [5]. P53 is one of the most 
important tumor-inhibiting genes, mutating 
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in half of the cancers. In general, the anti-
cancer effects of P53 occur in three different 
ways: 1-stimulation of DNA repair proteins, 
2- stimulation of programmed cell death, and 
3- stopping the cell cycle at the G1/S stage 
[28]. When DNA is damaged, the cell entry 
into the S or M stage is inhibited. In this case, 
concentration, and activity of P53 increases 
and gets activated from a nonactive form. 
The normal function of P53 is to protect the 
genome from damage. This process leads to 
the repair of the genome, and if not repaired, 
P53 causes cell apoptosis via cell death and 
deletes the carcinogenic cell [6]. Inhibition 
of P53 protein breakdown is therefore an 
appropriate strategy for the treatment of 
cancer [29]. GW9508 small molecules 
activate the mitochondrial pathway of 
apoptosis by binding to the GPR40 receptor; 
thus increasing the expression of the P53 
gene and inhibiting its degradation. The P53 
gene, in turn, inhibits the cell cycle in the G1 




     Since the GW9508 small molecule is an 
agonist for GPR40, it can cause dose-
dependent anti-cancer effects by binding to 
this receptor and, therefore, it is a good 
option for cancer treatment given the anti-
cancer properties of unsaturated fatty acids 
after binding to the GPR40 receptor. Overall, 
the findings of this study coupled with those 
of previous ones show that GW9508 small 
molecule can be considered a new 
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Name Primer Sequence  Tm (C) 
GAPDH (F) 5ˊACCTTGGAAATAAATGGGAAG-3ˊ 56.9 
GAPDH (R) 5ˊ- CTTCTGTGTTGCTGTAGTTGC3ˊ 57.1 
P53 (F) 5′-GTTTCCGTCTGGGCTTCTTG-3′ 64 
P53 (R) 5′-CCTGGGCATCCTTGAGTTCC-3′ 64 
Table 1. Primer sequences used 
 
